Sun Pharma Adv

Sector : Healthcare | Industry : Biotechnology & Medical Research

Follow

0 Followers

5
5
4
4
.
0
0
3
3
1
1
-1.35 (-1.02%)

As on 17 Oct, 25 | 13:05

Open Trading A/c
Day Range
130.15
133.55
L H
52 Week Range
109.20
240.95
L H
Volume
2,990.00

* BSE Market Depth ()

BUYSELL
QTYPRICEPRICEQTY
TotalTotal
 Bid / Ask
130.25/130.45

Sun Pharma Adv Quarterly Earnings

Sun Pharma Adv quarterly & annual earnings - Track stocks financial health, Earnings performance, key metrics like revenue, net profit, and growth trends. Compare stock's quarter on quarter metrics such as revenue, net income, operating margin, and earnings per share (EPS).

More insights like Forecast, Peer comparison, latest earnings transcripts & corporate action will help to overall analyse the stock's performance . Explore trends, track growth, and gain a deeper understanding of the company's strategy and market position with every quarterly release.

Read More[+]
  • Financial Performance
  • Results
  • Forecast
  • Peer Comparison

Financial Performance

Last Earnings Date
Q1 FY25-26 | 4th, Aug, 2025
Revenue
9
QoQ -64.55%
YoY-42.65%
Gross Profit
-54
QoQ -2.44%
YoY-43.25%
Net Profit
-51
QoQ -13.22%
YoY-45.91%
Best Quarters
Quarter Net Profit YoY Change%
No best quarters data
Worst Quarters
Quarter Net Profit YoY Change%
No worst quarter data

Earnings Forecast

Consolidated

EARNINGS FORECAST

ACTUALS
ESTIMATES
QUARTERLY (Rs.)
No Quarterly Earnings Forecast data for the stock
  • Net Profit
  • Revenue
  • EPS

peers comparison

Stock Name
Price
Mcap (Rs cr)
EPS
Estimated EPS
Revenue
Revenue Growth YoY%
Net Profit
Net Profit YoY%

Earnings reviewPro Exclusive

  • Earnings Transcript
  • Investor Presentations
    Show More

    Sun Pharma Advanced Research Company Quarterly Results

        0

        Corporate action

        • Announcements
        • Board Meetings
        • Bonus
        • More

          Frequently Asked Questions

          What is the Latest Results for Sun Pharma Advanced Research Company Ltd.

          Upcoming Earnings date for Sun Pharma Advanced Research Company Ltd. is 4th, Aug, 2025.

          What is the net profit reported by Sun Pharma Advanced Research Company Ltd. in Q1 FY25-26

          Sun Pharma Advanced Research Company Ltd. reported a net profit of Rs -51.

          What is the Revenue Earned by Sun Pharma Advanced Research Company Ltd.?

          Sun Pharma Advanced Research Company Ltd. reported a revenue earned of Rs 9.

          What is the dividend declared in the current financial year?

          Sun Pharma Advanced Research Company Ltd. has declared a dividend of Rs undefined on --.

          What was the last bonus declared by Sun Pharma Advanced Research Company Ltd.

          The last bonus declared by Sun Pharma Advanced Research Company Ltd. was on --.

          What is the reported EPS & estimated EPS for Sun Pharma Advanced Research Company Ltd.

          The reported EPS for Sun Pharma Advanced Research Company Ltd. is -- and the estimated EPS is --.

          What is the Latest Results for Sun Pharma Advanced Research Company Ltd.

          Upcoming Earnings date for Sun Pharma Advanced Research Company Ltd. is 4th, Aug, 2025.

          What is the net profit reported by Sun Pharma Advanced Research Company Ltd. in Q1 FY25-26

          Sun Pharma Advanced Research Company Ltd. reported a net profit of Rs -51.

          What is the Revenue Earned by Sun Pharma Advanced Research Company Ltd.?

          Sun Pharma Advanced Research Company Ltd. reported a revenue earned of Rs 9.

          What is the dividend declared in the current financial year?

          Sun Pharma Advanced Research Company Ltd. has declared a dividend of Rs undefined on --.

          What was the last bonus declared by Sun Pharma Advanced Research Company Ltd.

          The last bonus declared by Sun Pharma Advanced Research Company Ltd. was on --.

          What is the reported EPS & estimated EPS for Sun Pharma Advanced Research Company Ltd.

          The reported EPS for Sun Pharma Advanced Research Company Ltd. is -- and the estimated EPS is --.